Results 281 to 290 of about 198,685 (310)

Nanoparticle Albumin-Bound Paclitaxel and Nivolumab for PD-1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma. [PDF]

Cancer Med
Adkins D, Ley JC, Auberle C, Knapp B, Zaretsky J, Liu J, Oppelt P.   +6 more
europepmc   +1 more source

Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC)

Chenxi Li, S. Deng
openalex   +1 more source

Trends in the Use of Neoadjuvant Systemic Therapy for Head and Neck Squamous Cell Carcinoma.

JAMA Netw Open
Cai WL, Helou V, Carlson KM, Mazul AL, Zandberg DP, Spector ME, Zevallos JP, Ferris RL, Contrera KJ.   +8 more
europepmc   +1 more source

The immunologic landscape of HRAS-mutant head and neck squamous-cell carcinoma. [PDF]

ESMO Open
Economopoulou P, Rampias T, Spathis A, Kotsantis I, Kyriazoglou A, Anastasiou M, Pantazopoulos A, Gomatou G, Margeli A, Papageorgiou M, Foukas P, Psyrri A.   +11 more
europepmc   +1 more source

Application of immunoPET imaging to enhance head and neck squamous cell carcinoma clinical management. [PDF]

Front Oncol
Almutairi WM, Zheng QH, Langer M, Oderinde OM.   +3 more
europepmc   +1 more source

MicroRNAs as Emerging Therapeutic Targets Modulating the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. [PDF]

Int J Mol Sci
Brata RD, Marcut L, Barb AC, Manole A, Ciolofan A, Dumitru CS, Zara F, Patrascu R.   +7 more
europepmc   +1 more source

Figure 2 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma

Sun Min Lim, Seong-san Kang, Dong Kwon Kim, Soo‐Hwan Lee, Chun‐Bong Synn, Sujeong Baek, Seung M. Yang, Yu J. Han, Mi H. Kim, Heekyung Han, Kwangmin Na, Young T. Kim, Mi Ran Yun, Jae Hwan Kim, Youngseon Byeon, Young Seo Kim, Jii Bum Lee, Min Hee Hong, Joshua C. Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung‐Ho Pyo, Byoung Chul Cho   +22 more
openalex   +1 more source